Maite Bourlon, Associate Professor and Head of the Urologic Oncology Clinic at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, shared on X:
“Proud to share about bladder cancer with Enrique Grande. Do not miss this episode!”
Quoting Springer Health+ IME:
“As the treatment landscape for advanced UC and MIBC rapidly evolves, ensure you understand the latest guidelines and evidence supporting new treatment strategies.
Press play on these vodcasts to hear expert insights.”
What Comes Next? Sequencing Therapies in Advanced UC
Maite Bourlon joins Enrique Grande in a 15-minute podcast discussing guideline-recommended treatment selection and sequencing in advanced urothelial carcinoma, the evolving role of biomarkers, and how newer therapies are redefining treatment success.
The episode is part of the educational program “Raising the Bar in Bladder Cancer Care: Collaborative Approaches to Treatment Selection, Application and Integration.
Learning Objectives
- Select and sequence guideline-recommended treatments for advanced urothelial carcinoma based on patient factors, prior therapies and emerging evidence.
- Evaluate clinical data supporting perioperative treatment strategies for muscle-invasive bladder cancer, including immunotherapy and antibody-drug conjugates.
- Apply patient-centered and multidisciplinary strategies to treatment decision-making and adverse event management.
Read more articles about Bladder Cancer on OncoDaily.